Volker Erfle
12Patents
6h-index
13Co-inventors
59Inventor score
Filing activity: Nov 13, 1991 → Jun 14, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6440422B1 | Recombinant MVA virus, and the use thereof | Emerging Cross-Sectional Technologies | 44 | Expired |
| US7049145B2 | Vaccinia virus MVA-E3L-knockout-mutants and use thereof | Emerging Cross-Sectional Technologies | 19 | Expired |
| US8197825B2 | Recombinant MVA virus and the use thereof | Emerging Cross-Sectional Technologies | 18 | Active |
| US6682742B1 | Vector for integration of heterologous sequences into poxviral genomes | Chemistry; Metallurgy | 17 | Expired |
| US6869793B2 | Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7767209B2 | Modified vaccinia virus Ankara (MVA) mutant and use thereof | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7183047B2 | Reporter gene construct for the detection of HIV Rev and HIV Tat | Chemistry; Metallurgy | 3 | Expired |
| US8153138B2 | Recombinant MVA virus | Emerging Cross-Sectional Technologies | 1 | Active |
| US7198934B2 | Recombinant MVA virus, and the use thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5770688A | Method and composition for the treatment of mammalian HIV infection | Human Necessities | 0 | Expired |
| US7150874B2 | Vector for integration of heterologous sequences into poxviral genomes | Chemistry; Metallurgy | 0 | Expired |
| US5582967A | Human cell line LC5 and its use | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.